开发和质量控制一个人群的药代动力学模型库的发展和质量控制为caspofungin
Nuo Xu1,2, Yufei Shi1,2, Yixue Wang3
1Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fudan University, Shanghai 201203, China.
卡斯波金的剂量需要仔细考虑患者的因素,如身体大小和肝功能,因为成年人暴露的程度低于儿童. 这凸显了个性化抗真菌治疗的必要性,以确保治疗的有效性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 计算生物学 计算生物学
背景情况:
- 卡斯波丁 (Caspofungin) 是一种类,是侵袭性真菌感染的主要治疗方法.
- 素的药理动力学 (PK) 的变化可能导致药物暴露低于最佳水平,治疗效率降低.
研究的目的:
- 为了创建一个caspofungin群体药理动力学 (popPK) 模型库.
- 评估在不同患者群体和环境中实现目标 (PTA) 的概率.
主要方法:
- 通过文献审查和使用rxode2.2.的R实现开发了一个popPK模型库.
- 通过比较研究和分析共变量影响进行质量控制.
- 利用蒙特卡洛模拟来估计PTA,并为个性化剂量策略提供信息.
主要成果:
- 包括13个一个或两个区间的模型,确定身体大小,肝功能和白蛋白作为关键的共同变量.
- 在儿科和成人患者之间观察到显著的药理动力学差异.
- 发现,在任何人群中,对于*C. albicans*或*C. parapsilosis*没有达到≥90%的PTA,但在*C. glabrata*的成年人研究中,在70%的成年人和100%的儿科研究中得到满足.
结论:
- 成年人暴露在卡斯波金的水平低于标准剂量的儿童.
- 身体大小,肝功能和血清白蛋白对于优化卡斯波金剂量至关重要.
- 进一步的研究是必不可少的,以充分阐明在儿童群体中caspofungin的药理动力学.
更多相关视频
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
07:16Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
相关概念视频
Analysis of Population Pharmacokinetic Data
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
